middle.news
How Biotron’s $2.5M Raise and Sedarex Buy Boost HBV Drug Prospects
9:26am on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
How Biotron’s $2.5M Raise and Sedarex Buy Boost HBV Drug Prospects
9:26am on Thursday 29th of January, 2026 AEDT
Key Points
Acquisition of Sedarex Limited completed
Raised $2.5 million through placement and entitlement offer
Lead HBV drug BIT-HBV001 shows superior antiviral activity to Tenofovir
Patent application filed for BIT-HBV001 and related compounds
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BIOTRON (ASX:BIT)
OPEN ARTICLE